GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Siloam International Hospitals Tbk (FRA:2LS) » Definitions » YoY EBITDA Growth

PT Siloam International Hospitals Tbk (FRA:2LS) YoY EBITDA Growth : 0.00% (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is PT Siloam International Hospitals Tbk YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. PT Siloam International Hospitals Tbk's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 0.00%.

PT Siloam International Hospitals Tbk's EBITDA per Share for the three months ended in Dec. 2024 was €0.00.


PT Siloam International Hospitals Tbk YoY EBITDA Growth Historical Data

The historical data trend for PT Siloam International Hospitals Tbk's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Siloam International Hospitals Tbk YoY EBITDA Growth Chart

PT Siloam International Hospitals Tbk Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 300.00 100.00 37.50 - -9.09

PT Siloam International Hospitals Tbk Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -33.33 - - -

PT Siloam International Hospitals Tbk YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

PT Siloam International Hospitals Tbk's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(0.01-0.011)/ | 0.011 |
=-9.09 %

PT Siloam International Hospitals Tbk's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(0.003-0.003)/ | 0.003 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Siloam International Hospitals Tbk YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of PT Siloam International Hospitals Tbk's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Siloam International Hospitals Tbk Business Description

Traded in Other Exchanges
Address
Jl. Boulevard Jend.Sudirman No. 15 Lippo Village, Fakultas Kedokteran Universitas Pelita Harapan, Lantai 32, Banten, Tangerang, IDN, 15810
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. The company manages and operates multiple hospitals in Jadebotabek. Siloam Hospitals makes investments in both technology and medical staff to offer a range of medical services. The company also manages Centers of Excellence that address medical cases requiring complex treatment. The company derives its revenue from inpatient and outpatient services. Inpatient services derive revenue from medical support and medical specialist services, drugs and medical supplies, and inpatient rooms. Outpatient services derive revenue from the delivery of medical support and medical specialist services; drugs and medical supplies; hospital facilities. Inpatient services are responsible for a majority of company revenue.

PT Siloam International Hospitals Tbk Headlines

No Headlines